Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Willmann

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 10, 2022
ESTRO ACROP guidelines for external beam radiotherapy of patients with complicated bone metastasesEva Oldenburger, Stephanie Brown, Jonas Willmann, et al.
JAAD International|June 15, 2026
Political determinants of melanoma: Global inequities in skin cancer careSophia Ma, Tarek Zieneldien, Ali Aljassabi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 25, 2025
Patterns of care in primary brain tumour Reirradiation: A survey by the ESTRO CNS focus GroupAndrada Turcas, Raphael Bodensohn, Elena Clerici, et al.
Clinical and Translational Radiation Oncology|June 12, 2023
Mortality during or shortly after curative-intent radio-(chemo-) therapy over the last decade at a large comprehensive cancer centerSebastian M Christ, Jonas Willmann, Philip Heesen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 24, 2025
Evaluation of the prognostic value of the ESTRO/EORTC classification of reirradiation in patients with non-small cell lung cancerKatja Dähler, Madalyne Day, Klara Kefer, et al.
Radiation Oncology (London, England)|May 1, 2025
Implementation of a comprehensive clinical quality assurance system in radiation oncologyAnja Alessandra Joye, Matea Zosso-Pavic, Jeannifer Beckmann, et al.
Clinical Lung Cancer|August 8, 2025
Rationale and Design of the AUSTRAL trial: An Open-Label, Multicenter, Phase II Study Evaluating Radiotherapy Followed by Durvalumab (MEDI4736) and Ceralasertib (AZD6738) in Stage III NSCLC Patients With Thoracic Relapses and/or Oligometastases After the PACIFIC RegimenAndrea Riccardo Filippi, Eliana Rulli, Diego Signorelli, et al.
Clinical and Translational Radiation Oncology|December 21, 2023
Dosimetric Analysis of Proximal Bronchial Tree Subsegments to Assess The Risk of Severe Toxicity After Stereotactic Body Radiation Therapy of Ultra-central Lung TumorsMaiwand Ahmadsei, Vinojaa Jegarajah, Riccardo Dal Bello, et al.
Technical Innovations & Patient Support in Radiation Oncology|September 19, 2025
A standardised workflow to manage the complexity of reirradiation and radiotherapy retreatments in clinical practiceMadalyne Day, Jonas Willmann, Panagiotis Balermpas, et al.
Clinical and Translational Radiation Oncology|October 24, 2024
Reirradiation - still navigating uncharted waters?Nicolaus Andratschke, Jonas Willmann, Ane L Appelt, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 10, 2022
ESTRO ACROP guidelines for external beam radiotherapy of patients with complicated bone metastasesEva Oldenburger, Stephanie Brown, Jonas Willmann, et al.
JAAD International|June 15, 2026
Political determinants of melanoma: Global inequities in skin cancer careSophia Ma, Tarek Zieneldien, Ali Aljassabi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 25, 2025
Patterns of care in primary brain tumour Reirradiation: A survey by the ESTRO CNS focus GroupAndrada Turcas, Raphael Bodensohn, Elena Clerici, et al.
Clinical and Translational Radiation Oncology|June 12, 2023
Mortality during or shortly after curative-intent radio-(chemo-) therapy over the last decade at a large comprehensive cancer centerSebastian M Christ, Jonas Willmann, Philip Heesen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 24, 2025
Evaluation of the prognostic value of the ESTRO/EORTC classification of reirradiation in patients with non-small cell lung cancerKatja Dähler, Madalyne Day, Klara Kefer, et al.
Radiation Oncology (London, England)|May 1, 2025
Implementation of a comprehensive clinical quality assurance system in radiation oncologyAnja Alessandra Joye, Matea Zosso-Pavic, Jeannifer Beckmann, et al.
Clinical Lung Cancer|August 8, 2025
Rationale and Design of the AUSTRAL trial: An Open-Label, Multicenter, Phase II Study Evaluating Radiotherapy Followed by Durvalumab (MEDI4736) and Ceralasertib (AZD6738) in Stage III NSCLC Patients With Thoracic Relapses and/or Oligometastases After the PACIFIC RegimenAndrea Riccardo Filippi, Eliana Rulli, Diego Signorelli, et al.
Clinical and Translational Radiation Oncology|December 21, 2023
Dosimetric Analysis of Proximal Bronchial Tree Subsegments to Assess The Risk of Severe Toxicity After Stereotactic Body Radiation Therapy of Ultra-central Lung TumorsMaiwand Ahmadsei, Vinojaa Jegarajah, Riccardo Dal Bello, et al.
Technical Innovations & Patient Support in Radiation Oncology|September 19, 2025
A standardised workflow to manage the complexity of reirradiation and radiotherapy retreatments in clinical practiceMadalyne Day, Jonas Willmann, Panagiotis Balermpas, et al.
Clinical and Translational Radiation Oncology|October 24, 2024
Reirradiation - still navigating uncharted waters?Nicolaus Andratschke, Jonas Willmann, Ane L Appelt, et al.
Pageof 9